Altered neurological function in mice immunized with early endosome antigen 1

BMC Neuroscience

Volumn 5, Issue , 2004, Pages

  Selak, Sanja ^a   Fritzler, Marvin J ^b  

^a INSTITUTO CAJAL   (Spain)

^b UNIVERSITY OF CALGARY   (Canada)

Author keywords

Animal Model; Autoantibodies; Autoimmunity; Endosome; Neurological Function

Indexed keywords

AMINO ACID; AUTOANTIBODY; EARLY ANTIGEN; EARLY ENDOSOME ANTIGEN 1; EPITOPE; PROTEIN ANTIBODY; RECOMBINANT ANTIGEN; UNCLASSIFIED DRUG;

AMINO ACID COMPOSITION; ANIMAL BEHAVIOR; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ARTICLE; BRAIN FUNCTION; CLINICAL FEATURE; CONTROLLED STUDY; ERROR; FORELIMB; HAPLOTYPE; HISTOCOMPATIBILITY; HUMAN; HUMAN CELL; IMMUNIZATION; MOUSE; MOUSE STRAIN; NEUROLOGIC DISEASE; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; NONHUMAN; OPEN FIELD TEST; PROTEIN TARGETING; STATISTICAL SIGNIFICANCE; STRENGTH; TASK PERFORMANCE; WALKING;

ANIMALS; AUTOANTIBODIES; AUTOANTIGENS; BEHAVIOR, ANIMAL; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; EPITOPES; FEMALE; FORELIMB; MEMBRANE PROTEINS; MICE; MICE, INBRED STRAINS; MOTOR ACTIVITY; NERVOUS SYSTEM DISEASES; PEPTIDE FRAGMENTS; RECOMBINANT PROTEINS; SPECIES SPECIFICITY; VESICULAR TRANSPORT PROTEINS;

EID: 2642545015     PISSN: 14712202     EISSN: None     Source Type: Journal    
DOI: 10.1186/1471-2202-5-2     Document Type: Article

References (23)

1. Wood MJA, Vincent A: Neuroprotective autoimmunity - a double-edged sword? Nature Med 2000, 6:383-385.
2. Vincent A: Measuring and evaluating the significance of autoantibodies in neurological disorders. Clinical and Applied Immunology Reviews 2002, 3:127-151.
3. Pletz MW, Duda PW, Kappos L, Steck AJ: Immune-mediated neuropathies: etiology and pathogenic relationship to aging processes. J Neuroimmunol 2003, 137:1-11.
4. Theofilopoulos AN: The basis of autoimunity: part II Genetic predisposition. Immunol Today 1995, 16:150-159.
5. Watson CS, Gametchu B: Membrane estrogen and glucocorticoid receptors - implications for hormonal control of immune function and autoimmunity. Immunopharmacology 2001, 1:1049-1063.
6. Selak S, Schoenroth L, Senécal J-L, Fritzler MJ: Early endosome antigen 1: An autoantigen associated with neurological diseases. J Invest Med 1999, 47:311-318.
7. Selak S, Mahler M, Miyachi K, Fritzler ML, Fritzler MJ: Identification of the B-cell epitopes of the early endosome antigen 1 (EEA1). Clin Immunol 2003, 109:154-164.
8. Magoulas C, Zatsepina OV, Jordan PW, Jordan EG, Fried M: The SURF-6 protein is a component of the nucleolar matrix and has a high binding capacity for nucleic acids in vitro. Eur J Cell Biol 1998, 75:174-183.
9. Black CM, Silman AJ, Herrick AI, Denton CP, Wilson H, Newman J, Pompon L, Shi-Wen X: Interferon-a does not improve outcome at one year in patients with diffuse cutaneous scleroderma. Arthritis & Rheumatism 1999, 42(2):299-305.
10. Wilson JM, de Hoop M, Zorzi N, Toh BH, Dotti CG, Parton RG: EEA1, a tethering protein of the early sorting endosome, shows a polarized distribution in hippocampal neurons, epithelial cells, and fibroblasts. Mol Biol Cell 2000, 11:2657-2671.
11. Parton RG, Dotti CG: Cell biology of neuronal endocytosis. J Neurosci Res 1993, 36:1-9.
12. Vincent A, Jacobson L, Plested P: Antibodies affecting ion channel function in acquired nuromyotonia, in seropositive and seronegative myasthenia gravis, and in antibody-mediated arthrogryphosis multiplex congenita. Ann N Y Acad Sci 1998, 841:482-495.
13. Whishaw IQ, Metz GA, Kolb B, Pellis SM: Accelerated nervous system development contributes to behavioral efficiency in the laboratory mouse: a behavioral review and theoretical proposal. Dev Psychobiol 2001, 39:151-170.
14. Mackay IR: Autoimmunity: Paradigms of Burnet and complexities of today. Immunol Cell Biol 1992, 70:159-171.
15. Fritzler MJ: Autoantibodies: diagnostic fingerprints and etiologic perplexities. Clin Invest Med 1997, 20:50-66.
16. Kuchroo VK, Anderson AC, Waldner H, Munder M, Bettelli E, Nicholson LB: T cell response in experimental autoimmune encephalomyelitis (EAE): role of self and cross-reactive antigens in shaping, tuning, and regulating the autopathogenic T cell repertoire. Annu Rev Immunol 2002, 20:101-23.:101-123.
17. Pette M, Fujita K, Wilkinson D, Altmann DM, Trowsdale J, Giegerich G, Hinkkanen A, Epplen JT, Kappos L, Wekerle H: Myelin autoreactivity in multiple sclerosis : Recognition of myelin basic protein in the context of HLA-DR2 products by T lumphocytes of multiple-sclerosis patients and healthy donors. Proc Natl Acad Sci USA 1990, 87:7968-7972.
18. Wall M, Southwood S, Sidney J, Oseroff C, del Guericio MF, Lamont AG, Colon SM, Arrhenius T, Gaeta FC, Sette A: High affinity for class II molecules as a necessary but not sufficient characteristic of encephalitogenic determinants. Int Immunol 1992, 4:773-777.
19. Infante AJ, Kraig E: Myasthenia gravis and its animal model: T cell receptor expression in an antibody mediated autoimmune disease. Int Rev Immunol 1999, 18:83-109.
20. Jermy A, Beeson D, Vincent A: Pathogenic autoimmunity to affinity-purified mouse acetylcholine receptor induced without adjuvant in BALB/c mice. Eur J Immunol 1993, 23:973-976.
21. Mu FT, Callaghan JM, Steele-Mortimer HS, Parton RG, Campbell PL, McCluskey J, Yeo JP, Tock EPC, Toh BH: EEA1, an early endosomal protein. J Biol Chem 1995, 270:13503-13511.
22. Fritzler MJ, Manns MP: Anti-mitochondrial antibodies. Clin Applied Immunol Rev 2002, 3:87-113.
23. Akbar SM, Yamamoto K, Miyakawa H, Ninomiya T, Abe M, Hiasa Y, Masumoto T, Horiike N, Onji M: Peripheral blood T-cell responses to pyruvate dehydrogenase complex in primary biliary cirrhosis: role of antigen-presenting dendritic cells. Eur J Clin Invest 2001, 31:639-646.